Health Insurance - Pharmacy Benefits Managers - Specialty Drugs
Sponsor: Nicholaus R. Kipke (District 31)Committee: Health and Government OperationsSubject: Insurance - HealthStatus: Referred to interim study by Health and Government Operations (as of Oct 24, 2013)
What this bill does
Official synopsis
Requiring the State Board of Pharmacy, in consultation with the University of Maryland School of Pharmacy, to specify the prescription drugs that may be considered specialty drugs by a pharmacy benefits manager; requiring the Board to publish in the Maryland Register a list of the prescription drugs that may be considered specialty drugs; requiring a pharmacy benefits manager to designate on a formulary only prescription drugs that are on the list of specialty drugs published by the Board; etc.
AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (0)
MGA witness listNo witness list on file. It is scraped after hearings are scheduled; check the MGA link above.